3'-OH-THC3'-Hydroxy-Δ9-tetrahydrocannabinol
THC metabolite hydroxylated on the side chain; more active than THC in animals.
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
C₂₁H₃₀O₃
CID 101594562
- Family
- Metabolite
- Molar mass
- 330.46 g/mol
Updated on
In plain terms
3'-hydroxy-THC is a transformed form of THC, oxidised on its side chain. It was described in animals, first in the lung. In tests in mice and dogs, it proved more active than THC itself.
Receptors and activity
Pharmacology
3'-hydroxy-Δ9-tetrahydrocannabinol is a Δ9-THC metabolite hydroxylated on the third carbon of the pentyl chain. Widman et al. (1975) isolated it, together with 4'-hydroxy-THC, as one of the two major metabolites formed by the perfused dog lung, whereas liver microsomes produced only small amounts. Handrick et al. (1982) found it 2 to 3 times more effective than Δ9-THC in behavioural tests in mice and dogs. The hydroxylation creates a stereocentre: Martin et al. (1984) showed that the S enantiomer is markedly more potent than the R on hypoactivity in mice, static ataxia in dogs and Δ9-THC discrimination in rats, and more active than Δ9-THC, whereas the two enantiomers were equivalent on hypothermia. The authors conclude that metabolism can activate or inactivate Δ9-THC depending on the metabolite formed. No affinity measurement at CB1 or CB2 receptors was found.
Key sources.
- Widman M, Nordqvist M, Dollery CT, Briant RH. Metabolism of Δ1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism. J Pharm Pharmacol 1975;27:842-848 (new tab)PMID 1493
- Handrick GR et al. 3'-Hydroxy- and (±)-3',11-dihydroxy-Δ9-tetrahydrocannabinol: biologically active metabolites of Δ9-tetrahydrocannabinol. J Med Chem 1982;25:1447-1450 (new tab)PMID 6296389
- Martin BR, Kallman MJ, Kaempf GF, Harris LS, Dewey WL, Razdan RK. Pharmacological potency of R- and S-3'-hydroxy-Δ9-tetrahydrocannabinol. Pharmacol Biochem Behav 1984;21:61-65 (new tab)PMID 6087379
- Harvey DJ. Further studies on the oxidative cleavage of the pentyl side-chain of cannabinoids: metabolism of 3'-hydroxy-Δ9-THC by the mouse. Xenobiotica 1989;19:1437-1447 (new tab)PMID 2559552
- Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers 2007;4:1770-1804 (new tab)PMID 17712819
- ANSM, consolidated list of substances classified as narcotics, updated 16 February 2026 (new tab)
History
- Source
- No occurrence in the plant is documented. 3'-OH-THC is a Δ9-THC metabolite hydroxylated on the pentyl chain, described in animals: a major metabolite in the perfused dog lung and a minor product of dog liver microsomes (Widman et al. 1975).
Metabolic pathway
No plant pathway. The molecule results from hydroxylation of the third carbon of the pentyl chain of Δ9-THC. In the dog, this route dominates in the perfused lung, whereas liver microsomes mainly form derivatives hydroxylated at 6 (terpenoid numbering) and at 7 (Widman et al. 1975). The enzymes responsible in humans were not found in the sources consulted.
Legal framework
- European Union
No schedule of the United Nations conventions names 3'-OH-THC: the 1971 Convention lists Δ9-THC and six tetrahydrocannabinol isomers, not their hydroxylated metabolites. The European Union keeps no list of its own; its status falls to each Member State's law. No marketing authorisation concerns it.
- France
3'-OH-THC is not named on any French list. The entry "Tetrahydrocannabinols, their esters, ethers, salts as well as the salts of the aforementioned derivatives" of the narcotics list (decree of 22 February 1990), moved to annex III by the ANSM decision of 6 February 2026, does not mention hydroxylated derivatives. The generic "benzo[c]chromene" clause of annex IV (decisions of 22 May and 3 June 2024) allows at position 3 an alkyl chain substituted by alkyl, cyclic or heterocyclic groups, without mentioning a hydroxyl group on the chain. No published decision settles its case; in practice, the molecule is met only in research work.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Metabolite
- Chemistry
C5 side chain
- Parent molecule
Active metabolite.
- Verification
Every fact on this entry was checked against its primary sources on 20 October 2026.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Widman M, Nordqvist M, Dollery CT, Briant RH. Metabolism of Δ1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism. J Pharm Pharmacol 1975;27:842-848 (new tab)PMID 1493
- Handrick GR et al. 3'-Hydroxy- and (±)-3',11-dihydroxy-Δ9-tetrahydrocannabinol: biologically active metabolites of Δ9-tetrahydrocannabinol. J Med Chem 1982;25:1447-1450 (new tab)PMID 6296389
- Martin BR, Kallman MJ, Kaempf GF, Harris LS, Dewey WL, Razdan RK. Pharmacological potency of R- and S-3'-hydroxy-Δ9-tetrahydrocannabinol. Pharmacol Biochem Behav 1984;21:61-65 (new tab)PMID 6087379
- Harvey DJ. Further studies on the oxidative cleavage of the pentyl side-chain of cannabinoids: metabolism of 3'-hydroxy-Δ9-THC by the mouse. Xenobiotica 1989;19:1437-1447 (new tab)PMID 2559552
- Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers 2007;4:1770-1804 (new tab)PMID 17712819
- ANSM, consolidated list of substances classified as narcotics, updated 16 February 2026 (new tab)
Identifiers
Names
- Common name
- 3'-Hydroxy-Δ9-tetrahydrocannabinol
- IUPAC name
- (6aR,10aR)-3-(3-hydroxypentyl)-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
- Other names
- 3'-hydroxy-THC · 3'-OH-Δ9-THC
Identifiers
- Formula
- C₂₁H₃₀O₃
- PubChem CID
- 101594562(new tab)
- InChIKey
- GWSPOZKXWMVVEN-YJEKIOLLSA-N
- SMILES
- CCC(CCC1=
CC(= C2[C@@H] 3C= C(CC[C@H] 3C(OC2= C1) (C) C) C) O) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.